Speakers
|
|    |
Keynotes
 Disruptive Drug Development: Driving the Necessary Innovation and Change to Pioneer the Next Frontier Craig Venter, Founder Celera Genomics, The Institute for Genomic Research, J.Craig Venter Institute J. Craig Venter, Ph.D., is regarded as one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research. He is Founder, Chairman, and President of the J. Craig Venter Institute (JCVI), a not-for-profit, research organization dedicated to genomic research and the exploration of social and ethical issues in genomics. Dr. Venter is also Founder and CEO of Synthetic Genomics Inc., a privately held company dedicated to commercializing genomic-driven solutions to address global needs such as new sources of energy and next generation vaccines. Dr. Venter and his team at the Venter Institute continue to blaze new trails in genomics. He is also one of the most frequently cited scientists, is the author of more than 250 research articles
 Changing Your Game – How Clinical Executives Can Succeed in the New Leaner Life Science Industry by Increasing Global Competitiveness and Driving Revenue and Profit Growth with Innovation Ram Charan, Author, The Game-Changer: How You Can Drive Revenue and Profit Growth with Innovation Execution Dr. Ram Charan is a highly sought after business advisor famous among senior executives for his uncanny ability to solve their toughest business problems. For more than thirty-five years, Dr. Charan has worked behind the scenes with top executives at some of the world's most successful companies, including GE, Verizon, Novartis, Dupont, Thomson Corporation, Honeywell, KLM, Bank of America, and MeadWestvaco.
 Crowdsourcing Clinical Development and Medical Innovation James Suroweiki , Columnist for The New Yorker, Author, The Wisdom of Crowds James Surowiecki is the foremost authority on how to harness the collective wisdom of your organization for competitive advantage. He has written a well-received book on the theory and practice of The Wisdom of Crowds—Why The Many Are Smarter Than The Few And How Collective Wisdom Shapes Business, Economies, Societies And Nations. In The Wisdom of Crowds, Jim describes systematic ways to organize and aggregate the intelligence available in your organization in order to arrive at superior decisions—often better than those that individuals would make, even if they are 'experts'. The book and Jim's presentations based on the book are full of insights into how groups operate that are invaluable to business leaders. He also offers practical methods, tailored to his audience, for leveraging people and technology to learn what you need to know and make decisions that really serve the organization's goals. Jim writes a twice-monthly financial column for The New Yorker that is typically pegged to current events and incorporates the kind of insights from economics, sociology, and business history
 Capture and Navigate New Markets – Reset your Compass for Business Transformation by Profitably Tackling the Challenge of Entering New Markets, Wherever They Are Steve Wunker, Author, Capturing New Markets In addition to his entrepreneurial and corporate venturing experience, Steve was a long-term colleague of the leading innovation authority Harvard Business School Professor Clayton Christensen in building up his consulting practice, Innosight. Steve has co-written two articles with him and helped to put together his most recent book, The Innovator's Prescription. Since 2009,Wunker has led New Markets Advisors, which is dedicated to helping companies find, enter, and win in new markets. Before his entrepreneurial career, Steve was a strategy consultant at Bain and Company. Additionally, he worked at the United Nations to finance alternative energy and energy efficiency projects in emerging markets and lived around the global, including the US, UK, Netherlands, Japan, Ecuador, and Zambia.
 Women Leading Change with Impact Moira Forbes, Vice President and Publisher, ForbesWoman Moira Forbes is Vice President and Publisher, ForbesWoman and Associate Publisher, ForbesLife magazine. She is also the host of Success with Moira Forbes, a weekly video series featuring candid, one-on-one interviews with today's top women leaders. ForbesWoman is a multi-media platform serving successful women in business and leadership. This effort, launched by Forbes Media in 2008, includes a robust website, a digital community and a variety of content-rich live forums and events. Across these diverse media, ForbesWoman examines the unique experiences of professionally successful women, affirms their ambitions and achievements, and sets the agenda for purposeful discourse on the topics that matter most to them.
 Beating the Odds – Not Only Living with Cystic Fibrosis – Rocking It Emily Schaller, CF Patient, Clinical Trial Participant, Marathon Runner and Founder Rock CF Foundation Take one look at this native Detroiter and it's plain to see. Emily Schaller does not take guff. Equal parts spark and wit, Emily is claiming her victories against cystic fibrosis having launched Rock CF Foundation in summer of 2007. Today Emily's battle against this deadly genetic disease is printed in magazines and posted on websites, her greatest victories being raising $250,000 for cystic fibrosis research. She is a super teacher and a speaker. Emily teaches parents, patients and audiences in the CF world about the effects of cystic fibrosis and improvements being made to the treatments. She is a super athlete. Emily has ran over 1,000 miles, 6 half marathons and biked over 3,500 to keep healthy and raise funds for Rock CF. She is a super musician. Schaller organizes and rocks out at rock 'n roll CF benefit concerts.
"I am inspired and motivated to keep plugging away because I know for a fact that the money we raise is indeed helping to improve the lives of cystic fibrosis patients."
Mr. Zummo is Co-Head of J.P. Morgan Alternative Asset Management and Chief Investment Officer. He is head of the Portfolio Management Group and a member of the JPMAAM Investment Committee. Mr. Zummo co-founded JPMAAM in 1994. Prior to that, Mr. Zummo served as the manager of retirement plan investments for the Interpublic Group of Companies from 1992 to 1994, where he was responsible for analysis, asset allocation and manager selection. From 1990 to 1992 he worked at the former Chase organization as an investment analyst and consultant for institutional clients of the Chase Consulting Group. Mr. Zummo received a B.S. from the State University of New York at Albany and an M.B.A. from New York University. He holds the Chartered Financial Analyst (CFA) designation and is a member of the CFA Institute.
Deirdre Bevard, Vice President, Development Operations, Endo PharmaceuticalsView bio Deirdre BeVard is Vice President, Development Operations at Endo Pharmaceuticals. In this capacity she is responsible for the operational execution of clinical development of Endo's pipeline. This includes the clinical trial management, data management, clinical outsourcing and clinical quality control for study execution in support of Endo's key therapeutic areas. Endo utilizes a semi-virtual model for clinical development which retains key design, decision and oversight responsibilities while leveraging external partners to accommodate scalability, allowing the organization to continuously drive toward operational excellence. Deirdre is also actively involved in the business development activities that support the strategic therapeutic diversity of the organization through collaborative business partner relationships. Prior to joining Endo, Deirdre was Vice President, Clinical Services at ClearTrial, where she was responsible for the clinical services function supporting clinical trial operations planning and forecasting for client companies. Previous to that Deirdre developed a clinical site network as the Executive Director, Clinical Research for the Physician Alliance for Clinical Research (PACR). Deirdre was also Senior Director, Clinical Operations at Otsuka Pharmaceutical where she was responsible for global clinical trial operations, business process development and training, and clinical outsourcing. During her career at Otsuka she also had responsibility for other functions including Investigational Materials, Document Management and Meeting Planning. She has worked for a leading CRO, where she developed the company's first regional monitoring network, was responsible for project resource allocation, and the management, training and development of project staff in the US and Europe. Deirdre is a recipient of the 2010 HBA Rising Star Award and was selected as part of Endo's Accelerated Leadership Development Program. She has served on the Advisory Board for the IIR Partnerships Conference since 2006, was a member of the 2011 DIA Annual Meeting Program Committee, serves on advisory boards for other industry initiatives, and presents in multiple public courses and conferences in clinical development.  John Hubbard, SVP, Worldwide Head Development Operations, PFIZER INC | |
| Summit & Track Chairs Christina Bodurow, PhD, Senior Director, External Sourcing, Development Center of Excellence Eli Lilly Craig Lipset, Head of Clinical Innovation, Pfizer Inc. Deirdre Bevard, Vice President, Development Operations, Endo Pharmaceuticals Jeff Nau, MMS, VP, Medical & Clinical Affairs, NeoVista Incorporated Joe Popowicz, Director, Clinical Operations, Stryker John W. Hubbard, Senior Vice President, Worldwide Head Development Operations, Pfizer Inc. Jorge Guerra, Senior Vice President, Global Clinical Operations, Biogen Idec Joseph Kim, Director, Clinical Operations, Shire Pharmaceuticals Megan Weaver, Director of Global Clinical Operations, Biogen Idec. Ross Horsburgh, VP & Head of Clinical Development Asia Pacific Nycomed Mariette Boerstoel-Streefland, VP for Global Drug Safety, Forest Research Institute Meredith Smith, Senior Scientific Director – Risk Management, Abbott Labs Mitchell Katz, PhD, Executive Director, Medical Research Operations, Purdue Pharma Steve Whittaker, President and Independent Consultant, PharmaPM Consulting, LLC Pharma/Biotech/Medical Device Speakers Anne Harcarik, Director Clinical Operations, C.R. Bard Ann Wang, Vice President, Clinical Operations & Data Management, Human Genome Sciences, Inc. Bernard Munos, Chief Apostle, breakthrough innovation, InnoThink Center for Research in Biomedical Innovation Brenda Crowe, PhD, Research Advisor, Global Statistical Studies, Eli Lilly Bryant Wales, Vice President, Strategic Sourcing, ImClone Systems Carol Lewis-Cullinan, BC, FNP, Senior Director, Clinical Operations, AMAG Pharmaceuticals Inc. Chris Davis, Director, Global Strategic Sourcing, Eli Lilly Craig Coffman, Sr. Director, Clinical Business Operations & Outsourcing, Endo Pharmaceuticals Christina S. DiArcangelo, Chief Executive Officer, Armonia Clinical Research, LLC Cristina Damatarca, MD, Senior Safety Science Leader, GENENTECH-ROCHE Daniel Jacob, Medical Director – Global Pharmacovigilance, Baxter Healthcare David S. Reasner, Senior Vice President, Data Science - North America, Sunovion Pharmaceuticals Inc. David Tripi, Head of Healthcare Innovation, Janssen Donna Jarlenski, Head of Clinical Operations, Momenta Pharmaceuticals Donna Jarlenski, Head of Clinical Operations, Momenta Pharmaceuticals Ed Campanaro, Vice President of Clinical Operations, Cubist Pharmaceuticals, Inc. Frances Grote, Senior Director, Clinical Outsourcing Millennium Graeme Currie, Head, Clinical Project Management and Operations, Regeneron Pharmaceuticals Graeme Currie, Head, Clinical Project Management and Operations, Regeneron Pharmaceuticals Hakan Sakul, Executive Director & Head of Diagnostics, Pfizer Ira Spector, Senior Vice President Global Development Operations, Allergan Inc. Janelle Sabo, PharmD, RPh, CA-AM, Sr. Director, Global Clinical Trials Materials Services, Eli Lilly James Cai, VP of Clinical Development, aTyr Pharma Jessica Lee, MPH, Senior Director Clinical Development, Inovio Pharmaceuticals Inc. Jill Robinson, Senior VP for Global Patient Safety and Risk Management, Genzyme Johann Proeve Head Global Data Management Bayer Vital GmbH, Germany John L. LaMattina, PhD, Former President, Pfizer Global Research and Development and Senior Vice President, Pfizer Inc., Senior Partner Puretech Ventures John Lewis, Vice President of Public Affairs, Association of Clinical Research Organizations Justin Zamirowski, Director of Project Management, Otsuka Pharmaceuticals Kamal Shah, Head of Global Trials Safety Surveillance, Celgene Karen Brennan, Vice President, Clinical Development Operations, Millennium Pharmaceuticals Kenneth G. Olovich, R.Ph, MBA, Chief Procurement and Financial Officer Chorus Kevin Fain, Associate Chief Counsel for Drugs, former FDA Ron Corey, PhD, MBA, Vice President, Clinical and Project Management Asubio Pharmaceuticals, Inc. Lauren Goldsmith, Senior Manager, Purchasing & Strategic Outsourcing, MannKind Corporation Larry Blankstein PhD, Senior Director Clinical Development, Genzyme Corporation Lauren Meyers, Global Alliance Director, Genentech Lee Shieble, Strategic Sourcing Consultant, Eli Lilly Mario R. Ehlers, MD, PhD, Deputy Director, Clinical Trials Group, Immune Tolerance Network Mark Milberg, Senior Contract Manager, Clinical Contracting, Medtronic Mark Travers, PhD, VP, RCSM America, Regional Global Clinical Operations, Sanofi-Aventis Mary Rose Keller, Vice President Clinical Development and Operations, Sangart Matthew Emmens, Chairman and CEO, Vertex Pharmaceuticals Melanie Goodwin, Global Trial Optimization, Manager, Merck Michael Cox, Senior Manager, Outsourcing, MedImmune Miguel Orri MD, Senior Director, Pfizer Pharmaceuticals Nancy Widener, Executive Director, Clinical Science and Operations, Bristol-Myers Squibb Nina Spiller, Sr. Director, Global Clinical Development, OPDC, Otsuka Pharmaceuticals Peter Aurup, Senior Vice President, Global Research, Merck Peter de Veene, MD, European Qualified Person for Pharmacovigilance, Roche Peter Dibiaso, Senior Director Clinical Planning & Performance, Vertex Pharmaceuticals Ratan Ratnesh, Associate Director - Strategic Sourcing, Novartis Rehbar Tayyabkhan, Executive Director, Global Clinical Development, Bristol-Myers Squibb Rebecca Noel, Dr, PH, Research Scientist, Global Patient Safety, Eli Lilly Rene Sluijter, Global Head Outsourcing, Abbott Robert Walsh, MD, MBA, Senior Medical Director, Boston Scientific Scott Sawicki, Director, Clinical Contracting & Category Management, Novartis Stephen Porter, CEO, VDDI Pharmaceuticals Soloman Babani, Vice President, Alliance Management at Celtic Pharma & Celtic Therapeutics Songlin Xue, MD, PhD, Senior VP and Global Head of Pharmacovigilance, Takeda Pharmaceuticals International Stafford O’Kelly, President, Abbott Molecular Susan Gould, Senior Director, Clinical and Medical Affairs, Baxter Healthcare Theresa Musser, Vice President, Development Operations, Rigel Pharmaceuticals Todd Rich, SVP Development Innovation, Genentech (Roche) Zili Li, Head of Emerging Market Regulatory Strategy, Merck Academics and Sites Other Industry Experts CROs and Other Outsourcing Providers | |
